Tafasitamab

ATC L01FX12 · 8 markets · 11 records

Tafasitamab 8 markets · 11 records Forms

AU 3 records · 2 strengths

  • 200 mginjectionMINJUVIMINJUVI tafasitamab 200 mg powder for solution for infusion 1 vial per carton also in GB·ES·TW unknown

Records without a stated strength · 1 MINJUVI

US 2 records · 1 strengths

GB 1 records · 1 strengths

  • 200 mginjectionMinjuvi 200mg powder for concentrate for solution for infusion vials also in AU·ES·TW

CA 1 records · 1 strengths

ES 1 records · 1 strengths

TW 1 records · 1 strengths

HK 1 records · 1 strengths

    Records without a stated strength · 1 Minjuvi powder for concentrate for solution for infusion 200 mg

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 MINJUVI

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.